An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
LeMaitre to Participate at Upcoming Investor Conferences in November
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
LeMaitre Vascular, Inc. (Nasdaq:LMAT) will be participating in three upcoming investor conferences in November. The conferences include Jefferies London Healthcare Conference on November 14 in London, UK, where the Chief Financial Officer will present at 11:00 AM GMT. Stifel's 2023 Healthcare Conference will also take place on November 14 in New York City, with the President presenting at 1:50 PM ET. Lastly, the Piper Sandler 35th Annual Healthcare Conference will be held on November 29 in New York City, where the President will present at 2:10 PM ET.
Positive
None.
Negative
None.
BURLINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.
Jefferies London Healthcare Conference Tuesday, November 14, 2023 London, UK JJ Pellegrino, Chief Financial Officer, will present at 11:00 AM GMT
Stifel's 2023 Healthcare Conference Tuesday, November 14, 2023 Lotte NY Palace Hotel, New York City David Roberts, President, will present at 1:50 PM ET
Piper Sandler 35th Annual Healthcare Conference Wednesday, November 29, 2023 Lotte NY Palace Hotel, New York City David Roberts, President, will present at 2:10 PM ET
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
FAQ
What conferences will LeMaitre Vascular be participating in November 2023?
LeMaitre Vascular will be participating in three conferences in November 2023. These include the Jefferies London Healthcare Conference, Stifel's 2023 Healthcare Conference, and the Piper Sandler 35th Annual Healthcare Conference.
When and where will the Jefferies London Healthcare Conference take place?
The Jefferies London Healthcare Conference will take place on November 14, 2023, in London, UK.
Who will be presenting at the Jefferies London Healthcare Conference?
JJ Pellegrino, the Chief Financial Officer of LeMaitre Vascular, will be presenting at the Jefferies London Healthcare Conference.
When and where will Stifel's 2023 Healthcare Conference be held?
Stifel's 2023 Healthcare Conference will be held on November 14, 2023, at the Lotte NY Palace Hotel in New York City.
Who will be presenting at Stifel's 2023 Healthcare Conference?
David Roberts, the President of LeMaitre Vascular, will be presenting at Stifel's 2023 Healthcare Conference.
When and where will the Piper Sandler 35th Annual Healthcare Conference take place?
The Piper Sandler 35th Annual Healthcare Conference will take place on November 29, 2023, at the Lotte NY Palace Hotel in New York City.
Who will be presenting at the Piper Sandler 35th Annual Healthcare Conference?
David Roberts, the President of LeMaitre Vascular, will be presenting at the Piper Sandler 35th Annual Healthcare Conference.
lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.
